Business Context and Reporting Period
Company: Buda Juice, Inc. (formerly Buda Juice, LLC)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Year ended December 31, 2025
Business Overview: Buda Juice operates in the beverage industry, specializing in "UltraFresh" cold-crafted citrus-based juices, lemonades, and wellness shots. The company utilizes a centralized, high-tech production facility in Dallas, Texas, and an end-to-end cold chain logistics model to deliver perishable products to grocery retailers without heat treatment or pasteurization. The company operates as a single reportable segment.
Corporate Status: As of December 31, 2025, the company was a Texas LLC. On January 1, 2026, it converted to a Delaware corporation (Buda Juice, Inc.) and completed an Initial Public Offering (IPO) on January 9, 2026, listing on the NYSE American under the ticker "BUDA".
Key Financial Metrics
| Metric | 2025 (in thousands) | 2024 (in thousands) |
|---|---|---|
| Net Sales | $12,609 | $11,274 |
| Gross Profit | $5,629 | $5,209 |
| Gross Margin | 44.6% | 46.2% |
| Operating Income | $3,449 | $3,411 |
| Net Income | $3,533 | $3,574 |
| Cash and Cash Equivalents | $1,840 | $1,887 |
| Working Capital | $2,634 | $2,122 |
| Total Debt | $0 | $0 |
Debt and Liquidity: The company maintains a $3.0 million revolving line of credit with Amegy Bank. As of December 31, 2025, there were no outstanding borrowings. The facility is supported by personal guarantees from key directors. The company generated $3.15 million in cash from operating activities in 2025.
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased by 11.8% ($1.335 million) to $12.609 million, driven primarily by increased volume from the company's primary customer.
- Margin Compression: Gross margin decreased from 46.2% to 44.6%. This decline was attributed to increased costs of raw materials, specifically citrus produce.
- Operating Expenses: Total operating expenses rose 21.3% to $2.18 million. Selling, general, and administrative (SG&A) expenses increased 28.8% due to higher administrative personnel costs in preparation for the IPO, partially offset by the closure of remaining retail stores in 2024.
- Net Income: Net income decreased slightly by 1.4% ($41,000) to $3.533 million, reflecting the offset between revenue growth and rising input and administrative costs.
- Other Income: Other income dropped significantly by 88.5% to $29,000, largely due to the absence of a one-time $252,000 insurance recovery received in 2024 related to an employee misappropriation incident.
Guidance, Outlook, Risks, and Unusual Items
Outlook and Strategy
Management plans to fund geographic expansion through a three-facility hub model. The current Dallas facility serves 45 million consumers. A Southeast hub in South Carolina is projected for completion in 2026, and a Western hub in Arizona/Nevada is projected for 2027. The company intends to use IPO proceeds and operating cash flows to fund these capital expenditures.
Material Risks
- Customer Concentration: One customer accounted for 97% of net sales in 2025 (95% in 2024). The loss of this customer would have a material adverse impact.
- Supply Chain Vulnerability: The business relies on a strict cold chain. Disruptions in logistics, temperature excursions, or mechanical failures could result in product spoilage and reputational harm.
- Input Costs: The company depends on fresh citrus, which is subject to agricultural volatility, climate change, and potential tariffs (approx. 50% of citrus is imported from Mexico).
- Regulatory and Legal: Risks include food safety incidents, challenges to health/wellness marketing claims, and the complexities of transitioning to public company compliance (SOX 404).
Unusual Items
In 2024, the company recovered $103,000 in misappropriated funds via insurance, recorded as other income. No similar events occurred in 2025.
Investor Verification Checklist
- Customer Diversification: Verify the progress of efforts to reduce reliance on the single customer representing 97% of revenue.
- Capital Expenditures: Confirm the timeline and funding status for the planned South Carolina and Arizona/Nevada production hubs.
- Input Cost Management: Assess the company's ability to pass on rising citrus costs to retailers without losing shelf share.
- Post-IPO Liquidity: Review the utilization of the ~$18.4 million in net IPO proceeds (as of Jan 2026) against the projected capital needs for expansion.
- Internal Controls: Monitor the implementation of SOX 404 compliance, as the company was not subject to these requirements during the 2025 reporting period.